同和药业
(300636)
| 流通市值：32.33亿 | | | 总市值：36.96亿 |
| 流通股本：3.67亿 | | | 总股本：4.20亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 636,241,288.48 | 427,422,152.61 | 186,897,547.53 | 758,890,499.03 |
| 营业收入 | 636,241,288.48 | 427,422,152.61 | 186,897,547.53 | 758,890,499.03 |
| 二、营业总成本 | 520,768,052.25 | 341,667,938.34 | 161,677,017.83 | 626,890,162.6 |
| 营业成本 | 440,889,800.95 | 292,995,437.49 | 135,347,468.09 | 508,368,427.26 |
| 税金及附加 | 5,252,146.68 | 3,804,496.56 | 2,274,797.03 | 7,826,914.18 |
| 销售费用 | 19,980,796.6 | 11,531,947.55 | 5,248,872.85 | 29,938,037.83 |
| 管理费用 | 26,851,968.98 | 17,625,388.37 | 9,298,371.02 | 38,281,977.74 |
| 研发费用 | 41,033,872.63 | 26,648,811.91 | 14,140,941.15 | 59,447,007.04 |
| 财务费用 | -13,240,533.59 | -10,938,143.54 | -4,633,432.31 | -16,972,201.45 |
| 其中:利息费用 | 9,543,924.37 | 6,508,375.87 | 2,988,280.14 | 18,141,989.96 |
| 其中:利息收入 | 19,956,218.01 | 13,800,458.74 | 6,932,846.19 | 30,220,277.53 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 36,705.11 | 36,683.33 | 36,683.33 | 49,700 |
| 加:投资收益 | -747,741.82 | -280,829.37 | -103,289.22 | 574,934.35 |
| 资产处置收益 | -194,305.92 | -194,305.92 | -104,602.83 | -1,168,164.38 |
| 资产减值损失(新) | -31,639,391.53 | -26,621,114.78 | -6,698,790.66 | -26,567,161.93 |
| 信用减值损失(新) | -1,483,876.67 | -946,474.7 | -411,904.22 | -1,312,914.78 |
| 其他收益 | 10,290,433 | 6,833,409.14 | 4,106,508.64 | 7,824,109.35 |
| 四、营业利润 | 91,735,058.4 | 64,581,581.97 | 22,045,134.74 | 111,400,839.04 |
| 加:营业外收入 | 682,342.22 | 51.02 | 51.02 | 4,050,034.18 |
| 减:营业外支出 | - | - | - | 760,965.06 |
| 五、利润总额 | 92,417,400.62 | 64,581,632.99 | 22,045,185.76 | 114,689,908.16 |
| 减:所得税费用 | 8,752,809.58 | 6,095,120.42 | 1,263,808.79 | 8,105,805.99 |
| 六、净利润 | 83,664,591.04 | 58,486,512.57 | 20,781,376.97 | 106,584,102.17 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 83,664,591.04 | 58,486,512.57 | 20,781,376.97 | 106,584,102.17 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 83,664,591.04 | 58,486,512.57 | 20,781,376.97 | 106,584,102.17 |
| 扣除非经常损益后的净利润 | 76,288,014.46 | 53,686,419.63 | 17,680,554.97 | 99,620,207.05 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 0.14 | 0.05 | 0.25 |
| (二)稀释每股收益 | 0.2 | 0.14 | 0.05 | 0.25 |
| 九、综合收益总额 | 83,664,591.04 | 58,486,512.57 | 20,781,376.97 | 106,584,102.17 |
| 归属于母公司股东的综合收益总额 | 83,664,591.04 | 58,486,512.57 | 20,781,376.97 | 106,584,102.17 |
| 公告日期 | 2025-10-25 | 2025-08-29 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |